The results showed NFIB expression was upregulated in prostate adenocarcinoma according to Wallace’s dataset (Wallace et al., 2008), however, the opposite results were found in Tomlins’s study (Tomlins et al., 2007). The gene discussed is NFIB; the disease is prostate adenocarcinoma.